Intracranial collision metastases of prostate and esophageal carcinoma

Dewan, Sheri; Alvarez, Victor E.; Donahue, John E.; Cielo, Deus

doi:10.1007/s11060-009-9909-1

Cited by 12 publications

(7 citation statements)

References 14 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…In the present study, peripherally enhanced thin cyst walls (37/62, 59.7%) were more frequently observed compared to other common metastatic brain tumors. In Table 4, imaging features of brain metastases associated with esophageal carcinomas that have been published since 2004 [2,[11][12][13][14][15][16][17][18][19] are presented. In particular, cystic, enhanced tumors with minimal edema were notable.…”

Section: Discussionmentioning

confidence: 99%

“…[5][6][7][8]11,16] However, the majority of esophageal carcinoma reports were still based on autopsies. [9,10] With the clinical application of MRI, a larger number of reports of esophageal carcinoma have been published, [2][3][4][12][13][14][15][17][18][19] although, few reports have described both MRI findings and clinical features. Worldwide, the incidence of brain metastases from esophageal carcinoma ranges from 0.3% to 13%.…”

Section: Introductionmentioning

confidence: 99%

See 1 more Smart Citation

Neuroimaging and clinical characteristics of brain metastases from esophageal carcinoma in Chinese patients

et al. 2014

View full text Add to dashboard Cite

show abstract

Section: Discussionmentioning

confidence: 99%

Section: Introductionmentioning

confidence: 99%

Neuroimaging and clinical characteristics of brain metastases from esophageal carcinoma in Chinese patients

et al. 2014

View full text Add to dashboard Cite

show abstract

“…This case may have been the first example of BM coincident with ganglioneuroma. As another example, a 72-yearold male patient with both prostate and esophageal cancer [45] underwent brain lesion resection, and the pathological findings comprised a 2.5-cm cerebellar lesion containing both esophageal and prostate cancer components.…”

Section: Conclusive Evidence For Ec Metastasis To the Brainmentioning

confidence: 99%

Incidence and treatment of brain metastasis in patients with esophageal carcinoma

Feng¹,

Zhang²,

Zheng³

et al. 2015

WJG

View full text Add to dashboard Cite

Brain metastasis from esophageal carcinoma (BMEC) is very rare, but its incidence has increased in the United States, Japan, China and other counties. Reports on BMEC have largely been focused on examining whether adjuvant therapy for esophageal cancer influences the survival duration of BMEC patients and on the imaging characteristics of BMEC determined using new medical equipment. The difference between different pathological types of esophageal cancer, especially adenocarcinoma and squamous cell carcinoma, is one important factor used to assess the influence of BMEC. Adjuvant therapy, including radiotherapy and chemotherapy, for esophageal cancer with different characteristics in different countries may affect BMEC treatment outcomes. The degree of popularization of advanced medical equipment is a major concern related to the prevalence of BMEC. Furthermore, targeted BMEC treatment is under development in developed countries. In this article, we reviewed the debate surrounding BMEC and analyzed BMEC studies from different perspectives.

show abstract

“…Most of them describe cases with collision tumors consisting of malignant astrocytoma (including glioblastoma) and meningioma3,6,7,9,10). There are also reports of collision tumors consisting of two different cerebral metastases2,8). In almost all of these cases, the collision tumor consists of at least one malignant entity, but in our case, the collision tumor consists of two benign entities.…”

Section: Discussionmentioning

confidence: 66%

Collision Tumor Composed of Meningioma and Cavernoma

Weigel

Schrey

et al. 2017

J Korean Neurosurg Soc

View full text Add to dashboard Cite

A true collision tumor is a rare entity composed of two histologically distinct neoplasms coinciding in the same organ. This paper reports a unique case of cerebral collision tumor consisting of two benign components. On the first hand, meningioma which is usually a benign lesion arising from the meningothelial cell in the arachnoidal membrane. On the other, cerebral cavernoma which is a well-circumscribed, benign vascular hamartoma within the brain. To our knowledge, there is no previously documented case of cerebral collision tumor consisting of two benign components. A 56-year-old Caucasian male suffered in 2002 from an atypical meningioma WHO II° located in the left lateral ventricle. Three years after the tumor extirpation, the patient suffered from a hematoma in the fourth ventricle due to a recurrently haemorrhaged cavernoma. In 2008, a recurrence of the tumor in the left lateral ventricle was discovered. Additionally, another tumor located in the quadrigeminal lamina was detected. After surgical resection of the tumor in the left lateral ventricle, the pathological examination confirmed the diagnosis of a collision tumor consisting of components of a meningioma WHO II° and a cavernoma. Postoperatively, no adjuvant treatment was needed and no tumor recurrence is discovered up to the present. A possible explanation for the collision of those two different tumors may be migration of tumor cells mediated by the cerebrospinal fluid. After 5-years of follow-up, there is no sign of any tumor recurrence; therefore, surgical tumor removal without adjuvant therapy seems to be the treatment of choice.

show abstract

Intracranial collision metastases of prostate and esophageal carcinoma

Cited by 12 publications

References 14 publications

Neuroimaging and clinical characteristics of brain metastases from esophageal carcinoma in Chinese patients

Neuroimaging and clinical characteristics of brain metastases from esophageal carcinoma in Chinese patients

Incidence and treatment of brain metastasis in patients with esophageal carcinoma

Collision Tumor Composed of Meningioma and Cavernoma

Contact Info

Product

Resources

About